Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma

被引:43
作者
Hamana, K
Uzawa, K
Ogawara, K
Shiiba, M
Bukawa, H
Yokoe, H
Tanzawa, H
机构
[1] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chuo Ku, Chiba 2608670, Japan
[2] Chiba Univ Hosp, Div Dent & Oral Maxillofacial Surg, Chuo Ku, Chiba 2608670, Japan
[3] Chiba Univ, Grad Sch Med, Ctr Excellence Program 21st Century, Chuo Ku, Chiba 2608670, Japan
关键词
oral squamous cell carcinoma; allelic imbalance; serum DNA; circulating tumour DNA; prognosis;
D O I
10.1038/sj.bjc.6602635
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Frequent allelic imbalances (AIs) including loss of heterozygosity and microsatellite instability on a specific chromosomal region have been identified in a variety of human malignancies. The objective of our study was to assess the possibility of prognostication and monitoring of oral squamous cell carcinoma (SCC) by microsatellite blood assay. DNA from normal and tumorous tissues and serum DNA obtained at three time points (preoperatively, postoperatively, and 4 weeks postoperatively) from 64 patients with oral SCC was examined at nine microsatellite loci. In all, 38 (59%) DNA samples from tumorous tissues and 52% from serum showed AIs in at least one locus. Patterns of AIs in the serum DNA were matched to those detected in tumour DNA. Of them, AIs were frequently detected preoperatively (44%, 28 of 64), and postoperatively (20%, 13 of 64). Moreover, among 12 cases with AIs during the postoperative period, six had no evidence of an AI 4 weeks postoperatively, and they had no recurrence and were disease free. In contrast, six patients with AI-positive DNA 4 weeks postoperatively have died with distant metastasis within 44 weeks. Thus, our results suggest that the assessment of microsatellite status in the serum DNA could be a useful predictive tool to monitor disease prognosis.
引用
收藏
页码:2181 / 2184
页数:4
相关论文
共 24 条
[1]  
Coulet F, 2000, CANCER RES, V60, P707
[2]   Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients [J].
Diep, CB ;
Thorstensen, L ;
Meling, GI ;
Skovlund, E ;
Rognum, TO ;
Lothe, RA .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) :820-829
[3]  
Gonzalez MV, 1995, CLIN CANCER RES, V1, P1043
[4]  
Gonzalgo ML, 2002, CLIN CANCER RES, V8, P1878
[5]  
Lydiatt WM, 1998, HEAD NECK-J SCI SPEC, V20, P113, DOI 10.1002/(SICI)1097-0347(199803)20:2<113::AID-HED3>3.0.CO
[6]  
2-5
[7]  
Miyakawa A, 1998, INT J ONCOL, V13, P705
[8]  
Nakanishi H, 1999, ANTICANCER RES, V19, P29
[9]   Microsatellite alterations in serum DNA of head and neck cancer patients [J].
Nawroz, H ;
Koch, W ;
Anker, P ;
Stroun, M ;
Sidransky, D .
NATURE MEDICINE, 1996, 2 (09) :1035-1037
[10]   Microsatellite analysis of serum DNA in patients with head and neck cancer [J].
Nawroz-Danish, H ;
Eisenberger, CF ;
Yoo, GH ;
Wu, L ;
Koch, W ;
Black, C ;
Ensley, JF ;
Wei, WZ ;
Sidransky, D .
INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (01) :96-100